1. Home
  2. Molecular Templates

Tags : Molecular Templates

Vertex Collaborates with Molecular Templates to Discover and Develop Conditioning Regimens Enhancing Hematopoietic Stem Cell Transplants
Biotech

Vertex Collaborates with Molecular Templates to Discover and Develop Conditioning

Tuba Khan November 19, 2019

Shots: Molecular Templates (MTEM) to receive $38M up front including an equity investment, up to $522M as development, regulatory, commercial milestones, option payment for two targets and royalties on sales of products MTEM will conduct research activities to discover a new conditioning regimen utilizing its engineered toxin body (ETB) platform for up to two targets […]Read More

Takeda signs a Co-Development Agreement with Molecular Templates for CD38-Targeted Engineered Toxin Bodies(ETBs) for Multiple Myeloma
M&A

Takeda signs a Co-Development Agreement with Molecular Templates for CD38-Targeted

Vartika Singh September 20, 2018

Shots: Takeda will provide upfront of $30M and to pay royalties on commercialization. CD38-Targeted ETBs’ development cost will be shared equally between both the parties Molecular Templates will receive development, regulatory and commercial milestone payments of up to $632.5M if company exercise its co-development option, or $337.5M if it does not exercise or opts out […]Read More

Copyright ©2021 PharmaShots | Powered by Octavus Consulting